In beautiful LA for the 3rd National Ending the HIV Epidemic Partnerships for Research Meeting hosted by UCLA CHIPTS and UCLA CFAR where Lynn T. Matthews and DeAndre Tuyishime 5HorizonsHS are presenting on MOBILISE - increasing HIV testing in rural Alabama .UAB CFAR

Long-acting, injectable anti-retroviral therapy may offer a path forward for people with HIV to achieve suppression. bit.ly/3J1I0Bp @CROI2024 via Aadia Rana MD

Aadia Rana, M.D., professor in the Division of Infectious Diseases, senior scientist with the UAB Center for AIDS Research, and NIH-funded LATITUDE study chair, shares about the treatment's promising effectiveness in suppressing HIV. UAB CFAR UAB
uab.edu/news/health/it…

At #CROI2024 , aidsmap's Roger Pebody spoke to Aadia Rana MD from the University of Alabama at Birmingham about injectable treatment for people with adherence challenges.
Find out more and watch the full interview on aidsmap: aidsmap.com/news/mar-2024/…

.SDCFAR_Science & UAB CFAR: We're looking forward to this informative seminar by Aadia Rana MD on 03/22/24! Learn how community, academia & public health can work together to #EndHIV ! Zoom: ow.ly/cqmz50QW0lk P/W: 543220

👍 People with #HIV who struggle with daily oral #ART should be offered long-acting formulations, study findings suggest. Aadia Rana MD, professor of medicine at UAB, told us at #CROI2024 the study broadens eligibility for the regimens.

Watch the video 👇 bit.ly/4acM7pO

Helio.com -The latest news from CROI, with clinician perspectives, interviews and insight, plus archives of past meetings.
VIDEO: People who struggle with daily HIV regimen should be offered long-acting injections
healio.com/news/infectiou…

Carlos del Rio Moupali Das, MD, MPH ACTG Network Aadia Rana MD Fantastic presentation by Aadia Rana MD at #CROI2024 showing that injectable treatment provides a fabulous response for people who have too often been left behind. Well done!

Incredibly proud of >9 yrs w/ ACTG Network LATITUDE study team & grateful to 400+ 'hardly reached' participants from 33 sites contributing to landmark findings presented @ #CROI2024 . Further detailed analysis to come-& of all the many lovely msgs, these 2 were ♥️♥️Jason Halperin

Important news:
Monthly CAB+RPV is superior to daily oral therapy in people with suppressed HIV Viral loads and who had struggled to take oral therapy- LATITUDE DSMB has reported contagionlive.com/view/breakthro…

Thrilling news to share!! A5359 team is thankful for all of the hard work of our ACTG Network study sites in engaging those 'hardly reached' and most importantly the trust of our study participants. Excited to share more about the study results .. stay tuned!

A wonderful visit TUSKEGEE UNIVERSITY w/Dr Vivian Carter & colleagues to plan an HIV research pathway program for Tuskegee students w/UAB CFAR; & learn from Ms Cynthia Wilson at the Legacy Museum the rich, living history of TU. Excited for this program as a critical part of EHE in AL!

The Impact of a Walk-In HIV Care Model for People who are Incompletely Engaged in Care: the Moderate Needs (MOD) Clinic

🔓 Open Access
🔗 bit.ly/3HDkdIB

Doxycycline Postexposure Prophylaxis for STIs in Women — Uncertain Benefit, Urgent Need | NEJM nejm.org/doi/full/10.10…

Congrats to Dr. Ray Jones for presenting his working during the Early Stage Investigator Poster Session at the CFAR Annual Meeting at John Hopkins University last week 🎉
Dr. Jones is a member of the #UABCFAR Inaugural Emerging Scientist Investigator Group!